About
Georg Vo Beiske is a Venture Partner at HealthCap and the CEO and co-founder of Tribune Therapeutics. Prior to joining HealthCap as a medical associate in 2019, Georg was a project manager leading a global development team at Bayer responsible for the technical development and manufacturing of a clinical-stage radiolabeled antibody. Georg joined Bayer following the acquisition of Healthcap portfolio company Algeta, where he joined the late-stage development of Xofigo in 2013. He holds an MSc in Pharmacy from the University of Oslo.
Sign up to see Georg Vo Beiske's full profile
Access investment thesis, focus areas, bio, and contact details for Georg Vo Beiske and 22,000+ other VC professionals.
HealthCap
Stockholm, SE